Abstract
Recent emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and subsequent containment procedures have impacted the world as never seen before. Therefore, there is considerable curiosity about the genome evolution related to the origin, transmission and vaccine impact of this virus. We have analysed genome sequences of SARS-CoV-2 isolated from Indian patients to gain an in-depth understanding of genomic evolution and transmission in India. Phylogenetic analysis and mutation profiling revealed major lineages being evolved by characteristic mutations. As the mutation frequency in spike protein is comparatively lesser, the candidate vaccines expected to have wide coverage worldwide including India.
Keywords: COVID-19, evolution, India, severe acute respiratory syndrome coronavirus 2, transmission, vaccine
References
- 1.Paraskevis D, Kostaki EG, Magiorkinis G, Panayiotakopoulos G, Sourvinos G, Tsiodras S. Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event. Infect Genet Evol. 2020;79:104212. doi: 10.1016/j.meegid.2020.104212. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Boni MF, Lemey P, Jiang X, Lam TT, Perry B, Castoe T, et al. Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic. bioRxiv; 2020. [DOI] [PubMed]
- 3.Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF. The proximal origin of SARS-CoV-2. Nat Med. 2020;26:450–452. doi: 10.1038/s41591-020-0820-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Li X, Giorgi EE, Marichannegowda MH, Foley B, Xiao C, Kong XP. Emergence of SARS-CoV-2 through recombination and strong purifying selection. Sci Adv. 2020:eabb9153. doi: 10.1126/sciadv.abb9153. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Liu P, Jiang JZ, Wan XF, Hua Y, Li L, Zhou J. Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)? PLoS Pathog. 2020;16:e1008421. doi: 10.1371/journal.ppat.1008421. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Becerra-Flores M, Cardozo T. SARS-CoV-2 viral spike G614 mutation exhibits higher case fatality rate. Int J Clin Pract. 2020;74:e13525. doi: 10.1111/ijcp.13525. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Banu S, Jolly B, Mukherjee P, Singh P, Khan S, Zaveri L, et al. A distinct phylogenetic cluster of Indian SARS-CoV-2 isolates. bioRxiv; 2020. [DOI] [PMC free article] [PubMed]
- 8.Koyama T, Parida L. Identification of a Low Pathogenicity Clade of SARS-CoV-2. Preprints.org; 2020.
- 9.Liu Y, Gayle AA, Wilder-Smith A, Rocklöv J. The reproductive number of COVID-19 is higher compared to SARS coronavirus. J Travel Med. 2020;27:???. doi: 10.1093/jtm/taaa021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Rajendrakumar AL, Nair AT, Nangia C, Chourasia PK, Chourasia MK, Syed MG, et al. Epidemic Landscape and Forecasting of SARS-CoV-2 in India. medRxiv; 2020. [DOI] [PMC free article] [PubMed]
- 11.Boulware DR, Pullen MF, Bangdiwala AS, Pastick KA, Lofgren SM, Okafor EC. A randomized trial of hydroxychloroquine as postexposure prophylaxis for COVID-19. N Engl J Med. 2020;383:517–525. doi: 10.1056/NEJMoa2016638. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Williamson BN, Feldmann F, Schwarz B, Meade-White K, Porter DP, Schulz J, et al. Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2. BioRxiv. 2020. [DOI] [PMC free article] [PubMed]
- 13.Somers EC, Eschenauer GA, Troost JP, Golob JL, Gandhi TN, Wang L, et al. Tocilizumab for treatment of mechanically ventilated patients with COVID-19. medRxiv. [DOI] [PMC free article] [PubMed]
- 14.Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;18:1094–1099. doi: 10.1111/jth.14817. [DOI] [PMC free article] [PubMed] [Google Scholar]